Eli Lilly and Co (LLY)
550.83
+0.70
(+0.13%)
USD |
NYSE |
Sep 22, 14:14
Eli Lilly Revenue (Quarterly): 8.312B for June 30, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 8.312B |
| March 31, 2023 | 6.96B |
| December 31, 2022 | 7.302B |
| September 30, 2022 | 6.942B |
| June 30, 2022 | 6.488B |
| March 31, 2022 | 7.81B |
| December 31, 2021 | 8.000B |
| September 30, 2021 | 6.773B |
| June 30, 2021 | 6.740B |
| March 31, 2021 | 6.806B |
| December 31, 2020 | 7.44B |
| September 30, 2020 | 5.741B |
| June 30, 2020 | 5.499B |
| March 31, 2020 | 5.860B |
| December 31, 2019 | 6.114B |
| September 30, 2019 | 5.477B |
| June 30, 2019 | 5.637B |
| March 31, 2019 | 5.092B |
| December 31, 2018 | 5.638B |
| September 30, 2018 | 5.307B |
| June 30, 2018 | 5.585B |
| March 31, 2018 | 4.964B |
| December 31, 2017 | 3.263B |
| September 30, 2017 | 5.658B |
| June 30, 2017 | 5.824B |
| Date | Value |
|---|---|
| March 31, 2017 | 5.228B |
| December 31, 2016 | 5.760B |
| September 30, 2016 | 5.192B |
| June 30, 2016 | 5.405B |
| March 31, 2016 | 4.865B |
| December 31, 2015 | 5.376B |
| September 30, 2015 | 4.960B |
| June 30, 2015 | 4.979B |
| March 31, 2015 | 4.645B |
| December 31, 2014 | 5.121B |
| September 30, 2014 | 4.876B |
| June 30, 2014 | 4.936B |
| March 31, 2014 | 4.683B |
| December 31, 2013 | 5.809B |
| September 30, 2013 | 5.773B |
| June 30, 2013 | 5.930B |
| March 31, 2013 | 5.602B |
| December 31, 2012 | 5.957B |
| September 30, 2012 | 5.443B |
| June 30, 2012 | 5.601B |
| March 31, 2012 | 5.602B |
| December 31, 2011 | 6.047B |
| September 30, 2011 | 6.148B |
| June 30, 2011 | 6.253B |
| March 31, 2011 | 5.839B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
5.092B
Minimum
Mar 2019
8.312B
Maximum
Jun 2023
6.497B
Average
6.614B
Median
Revenue (Quarterly) Benchmarks
| Amgen Inc | 6.986B |
| Biogen Inc | 2.456B |
| Johnson & Johnson | 25.53B |
| Merck & Co Inc | 15.04B |
| Pfizer Inc | 12.73B |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.763B |
| Total Expenses (Quarterly) | 5.974B |
| EPS Diluted (Quarterly) | 1.95 |
| Enterprise Value | 538.31B |
| Gross Profit Margin (Quarterly) | 78.26% |
| Profit Margin (Quarterly) | 21.21% |
| Earnings Yield | 1.29% |
| Operating Earnings Yield | 1.67% |
| Normalized Earnings Yield | 1.413 |